VARIPULSE catheter and TRUPULSE generator for persistent atrial fibrillation
Part of Heart & circulation clinical trials.
This study tests a new catheter and generator system to treat persistent atrial fibrillation (an irregular heartbeat that lasts more than a week). It may help people whose symptoms haven't been controlled by medication and who need a procedure called ablation to fix the heart's electrical signals.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with symptomatic persistent atrial fibrillation (a type of irregular heartbeat that doesn't stop on its own).
- You are scheduled to have a heart ablation procedure to treat your irregular heartbeat.
- You have tried at least one heart rhythm medication that didn't work or caused side effects.
- You are between 18 and 75 years old.
- You are willing to follow all study visits and requirements.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new catheter system to treat atrial fibrillation (AF) by creating small scars in the heart to block faulty signals. It may help people with symptoms that continue despite medication and who are scheduled for a standard ablation procedure.
This study tests a new catheter system, called Varipulse, to see if it's safe and effective for treating atrial fibrillation (AF), a heart rhythm problem. People with short-lasting AF who haven't been helped by medication may be able to join.
This study tests two types of pulsed field ablation catheters to treat persistent atrial fibrillation, a heart rhythm problem lasting more than 7 days but less than a year. The goal is to see if these catheters can safely and effectively restore a normal heart rhythm.
This study tests a new catheter to treat persistent atrial fibrillation (a type of irregular heartbeat lasting more than 7 days but less than a year). It aims to isolate the pulmonary veins and superior vena cava to restore normal rhythm. Some participants may also receive a left atrial appendage occlusion device if needed.
This trial studies a new catheter called Varipulse to treat paroxysmal atrial fibrillation (irregular heartbeats that come and go) in people whose symptoms are not controlled by medication or who can't tolerate the side effects. The procedure is done under optimized sedation to help you relax.
This study tests a special catheter that uses two types of energy to fix the irregular heartbeats in people with persistent atrial fibrillation (AFib). It aims to see if it's safe and effective in helping restore a normal heart rhythm.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.